Le Lézard
Classified in: Health, Science and technology, Business
Subject: CON

Think Research Secures Contract to Deliver Essential Data and Services Platform to New Customer

A Broad Range of Think Research Solutions Are Being Deployed to Help Solve Healthcare Access & Quality Challenges

TORONTO, Feb. 9, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, today announced that it entered into an agreement with a new customer on January 30, 2023, to provide a broad range of software solutions, data and subscription services to help improve access to quality healthcare. The value of this engagement is approximately $2.0 million.

Sachin Aggarwal, CEO, Think, said, "We are honoured and excited to leverage our solutions to help solve important healthcare access and delivery challenges. We believe that this deployment will help set the standard for digital health solutions to improve patient outcomes and save lives."

The scope of the essential data and services included in this engagement incorporate many of Think's platform applications.

About Think Research Corporation

Think Research Corporation is an industry leader in delivering knowledge-based digital health software solutions. The Company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process and standardize care, to facilitate better health care outcomes. The Company gathers, develops, and delivers knowledge-based solutions globally to customers typically including enterprise clients, hospitals, health regions, healthcare professionals, and / or governments. The Company has gathered a significant amount of data by building its repository of knowledge through its network and group of companies.

Think licenses its solutions to over 13,000 facilities for over 300,000 primary care, acute care, and long-term care doctors, nurses and pharmacists that rely on the content and data provided by Think to support their practices. Millions of patients and residents annually receive better care due to the essential data that Think produces, manages and delivers.

In addition, the Company collects and manages pharmaceutical and clinical trial data via its BioPharma Services subsidiary. BioPharma Services is a leading provider of bioequivalence and Phase 1 clinical research services to pharmaceutical companies globally. Think's other services include a network of digital-first primary care clinics and medical clinics that provide elective surgery. Visit: thinkresearch.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information: https://www.thinkresearch.com/ca/investors/

SOURCE Think Research Corporation

These press releases may also interest you

at 23:48
The Myntexchange is a wonderful example of the value of community being seen as one of the most valuable assets. The value of community in the crypto space The crypto space is reliant on its community, as a blockchain-based project is close to...

at 23:47
OKX, the world's second-largest crypto exchange by trading volume and a leading Web3 technology company, today published its fifth monthly Proof of Reserves (PoR) showing $8.9 billion USD held by the exchange in...

at 23:35
Rokid, China's leading augmented reality company, today announces its next-generation AR glasses - Rokid Max, which are only 75g lightweight and compact, but offer an excellent MAX-theater experience. Equivalent to a 215-inch large screen viewed from...

at 23:33
PT Bank Rakyat Indonesia (Persero) Tbk. (IDX: BBRI) was awarded the Market Leader and Best Service categories in the Euromoney Trade Finance Awards 2023. This is in recognition of their efforts to strengthen superior financial services, in line with...

at 23:00
The industrial enclosures market size is estimated to increase by USD 2,237.84 million from 2022 to 2027, with a CAGR of 5.16%, according to a recent market study by Technavio. The increase in the use of electrical and electronic equipment in...

at 22:56
Chinese leading biopharmaceutical company 3SBio (01530.HK) today announced its 2022 annual results. In 2022, 3SBio's core biopharmaceutical products posted robust growth, hair health business achieved blistering performance, and contract development...

News published on 9 february 2023 at 07:30 and distributed by: